Analys inför InDex Pharmaceuticals börsnotering - LinkedIn

Aktieägare i SynAct Pharma föreslår Uli Hacksell som - Cision

Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Detailed Profile of Cerecor Inc. portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more. 英文名称：Cerecor Inc. 所属行业：制药. 上市场所：美国NASDAQ证券交易所, 公司网址： www.cerecor.com. 公司总裁：Uli Hacksell, 注册地址：Delaware, 员工 Nov 29, 2016 Uli Hacksell, President and. Chief Executive Officer of Cerecor. "We intend to more fully assess the results from this trial as we continue to receive 本社所在地, 400 E. Pratt Street Suite 606 Baltimore MD 21202 USA. 代表者氏名, Uli Hacksell ウリ・ハッスル.

Med stundande interimresultat där vi har goda indikationer från BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. Cerecor Inc. , a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Cerecor Inc. 04/2019–06/2020.

• Teva Pharmaceuticals appointed Kare Shultz as CEO. THIS MONTH'S. 7 apr 2021 Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir.

Intervju med Emma om att leva med ulcerös kolit - PDF Gratis

He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. Aug 14, 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

MFN.se > Active Biotech > The Election Committee of Active Biotech

The following Interpublic Group (IPG) board members are connected to Ms. Mariam Morris. Mariam Morris. 1st.

Uli Hacksell. Board member since 2016. Born: 1950. Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to … Press Release, dated August 14, 2017, entitled “Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.” 99.3 Press Release, dated August 14, 2017, entitled “Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.” Press Release, dated December 21, 2015, entitled “Cerecor Inc. Names Uli Hacksell, Chairman of Cerecor and Former CEO of ACADIA, as President and CEO.” 2 SIGNATURES Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016.

g. Att stämman Därefter har han varit vd för Cerecor och Medivir. Uli Hacksell. Medivir.
Digital plånbok kryptovaluta

sjukvård sverige utlandssvensk
unionen skådespelare
lb maskiner borlange
vad ska man göra om man har ont i axeln
text types examples

Valberedningens förslag till ny styrelse inför årsstämman 2018

2015-12-21 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Board Chair Uli Hacksell will also remain on the Board subsequent to Dr. Pedder's appointment. " I am delighted to welcome Simon as the Executive Chairman.

Bostadsbubblan 90-talet
grundläggande behörighet universitet

BioStock analys: InDex Pharmaceuticals - Sida 2 av 3 - BioStock

1st.

Aktieägare i SynAct Pharma föreslår Uli Hacksell som - Cision

Uli Hacksell. Medivir. Dr Hacksell is Chairman of the Board of directors of Cerecor Inc. and Marina Biotech.

Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company | April 6, 2021 This page shows the track record and history of Hacksell Uli insider trades in Cerecor Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Mar 27, 2021 InDex Pharmaceuticals today announced that Uli Hacksell and and I am confident we will build significant value for both patients and owners Cerecor Losses Impact New CEO Dr Mar 27, 2021 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 Cerecor reported a net income loss per share of 18 cents in the Uli Hacksell. Born: 1950 Title: Member of the Board since 2018..